We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Pictet Biotech Class I - Income (GBP)

Sell:143,053.00p Buy:143,053.00p Change: 1,377.00p (0.97%)
Prices as at 24 July 2026
Sell:143,053.00p
Buy:143,053.00p
Change: 1,377.00p (0.97%)
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
Prices as at 24 July 2026
Sell:143,053.00p
Buy:143,053.00p
Change: 1,377.00p (0.97%)
Prices as at 24 July 2026
You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Asset Allocation

X-ray asset allocation
Key % Net Assets
International Equities 97.44%
Mutual Funds 2.50%
UK Equities 0.99%
Cash and Equiv. -0.94%

Top 10 holdings

Stock name % Weight Country Sector
1 UNITED THERAPEUTICS CORPORATION 4.63% USA Pharmaceuticals & Biotechnology
2 REGENERON PHARMACEUTICALS INC 4.59% USA Pharmaceuticals & Biotechnology
3 BIOGEN 4.57% USA Pharmaceuticals & Biotechnology
4 INSMED INCORPORATED 3.90% USA Pharmaceuticals & Biotechnology
5 GILEAD SCIENCES 3.69% USA Pharmaceuticals & Biotechnology
6 MADRIGAL PHARMACEUTICALS INC 3.00% USA Pharmaceuticals & Biotechnology
7 AMGEN 2.98% USA Pharmaceuticals & Biotechnology
8 ARGENX SE 2.98% NLD Pharmaceuticals & Biotechnology
9 IONIS PHARMACEUTICALS 2.90% USA Pharmaceuticals & Biotechnology
10 BRIDGEBIO PHARMA 2.80% USA Pharmaceuticals & Biotechnology

Fund Analysis is only available on the desktop version of our website. This can be accessed using a desktop or laptop PC or some larger tablets.

You can buy or sell holdings in this fund through a Stocks and Shares ISA, Lifetime ISA, SIPP or Fund and Share Account